Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Advanced Enzyme Technologies Limited Regulatory Filings 2021

Jun 16, 2021

62369_rns_2021-06-16_fb473d83-317e-44be-8422-b90fc63af6bb.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

June 16, 2021

BSE Limited National Stock Exchange of India Limited Department of Corporate Affairs Exchange Plaza, Plot No. C/1, G Block P. J. Towers, Dalal Street, Bandra-Kurla Complex, Bandra (E) Mumbai-400 001 Mumbai-400 051 Scrip ID-540025 Scrip Code-ADVENZYMES

Dear Sir/Madam,

Sub: Intimation of Analyst / Institutional Investor Meeting under the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015

Pursuant to SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform the following schedule of the Analyst / Investor Meeting of the Company at S-Ancial’s Capital Market Outreach Conference:

Date Interaction With Type & details
June 17, 2021 Analysts / Investors at S-Ancial’s CapitalMarket Outreach Conference Virtual Group Meeting

Note: The aforesaid is subject to change. Changes may happen due to exigencies on the part of Fund/Company.

The aforesaid information is also being uploaded on the Company’s website.

You are requested to kindly take a note of the same.

Thanking you, Yours faithfully, For Advanced Enzyme Technologies Limited

Digitally signed by SANJAY SANJAY PRAKASH PRAKASH BASANTANI BASANTANI Date: 2021.06.16 16:50:12 +05'30' ________________

Sanjay Basantani Company Secretary and Head – Legal